StockData
Nyxoah SA logo

Nyxoah SA (NYXH) stock

NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$0.81−0.05 (-6.25%)

Close on Nov 20, 2026Market cap $34.64MP/E –Yield –

Nyxoah operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Nyxoah's operating income for the twelve months ending Dec 31, 2022 was -€32.50M. For fiscal 2025 it was -€83.49M. The highest annual figure on record is -€11.22M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€83.49M–
FY2024Dec 31, 2024-€58.81M–
FY2023Dec 31, 2023-€45.10M–
FY2022Dec 31, 2022-€32.50M–
FY2021Dec 31, 2021-€26.24M–
FY2020Dec 31, 2020-€11.22M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-€20.59M–
Q2 FY2025Jun 30, 2025-€19.85M–
Q2 FY2024Jun 30, 2024-€13.31M–
Q2 FY2023Jun 30, 2023-€11.88M–
Q4 FY2022Dec 31, 2022-€9.05M–
Q3 FY2022Sep 30, 2022-€8.78M–
Q2 FY2022Jun 30, 2022-€7.39M–
Q4 FY2021Dec 31, 2021-€6.54M–
Q3 FY2021Sep 30, 2021-€8.07M–

More Nyxoah figures

See a number that looks wrong?